Connect with us

National

Moderna coronavirus vaccine candidate moves to phase 3 with 30,000 participants – News-Medical.Net

The world’s most significant coronavirus disease (COVID-19) vaccine study is underway in the United States, with a planned 30,000 volunteers. The phase 3 clinical trial aims to examine the efficacy and safety of the candidate vaccine developed by the National…

Published

on

The world’s most significant coronavirus disease (COVID-19) vaccine study is underway in the United States, with a planned 30,000 volunteers. The phase 3 clinical trial aims to examine the efficacy and safety of the candidate vaccine developed by the National Institutes of Health and Moderna Inc.
The U.S. biotech firm Moderna announced that it had started the final stage of its human trials for its experimental COVID-19 vaccine in the U.S. The phase 3 human clinical trial comes after the compan…

Click here to view the original article.